The effector function of CD8+ T cells in the spleen and lymph nodes were comparable in mice inoculated with RBMS1-depleted or control 4T1 cells (Fig. 2G, H), indicating that the difference in the intratumoral CD8+ T cell effector function was due to the tumor microenvironment. This evidence concerns the gene CD8A and neoplasm.